Integral Privacy Technologies Raises $25M to Build the Privacy Layer for AI's Real-World Data Push

Integral Privacy Technologies has raised $25 million in total funding, with backing from Venrex, The General Partnership, Array Ventures, GreatPoint Ventures, LiveRamp Ventures, Haystack, Virtue Ventures, Also Capital, Caffeinated Capital, LifeX Ventures, Circle & Co, and WS Investments. The round is aimed at scaling what the company calls its Forward Deployed Privacy Services — a service layer meant to make sensitive real-world data usable for AI training without triggering the regulatory and re-identification risks that normally keep that data locked away.

The Problem: Public Data Is Running Out

The framing here matters for anyone tracking where AI training data is headed next. The first generation of large models was trained largely on public web data and human-curated datasets. That well is drying up relative to demand, and AI builders are now pushing into health records, financial transactions, customer interaction logs, operational systems, and codebases — data that carries real decision-making complexity but also carries contractual and regulatory exposure that public data simply doesn’t have.

Enterprises sitting on this data increasingly see it as a monetizable asset, but raw real-world data is legally and technically difficult to hand over. Masking and synthetic data generation have become commodity capabilities available in most modern data stacks — that’s no longer the differentiator. What Integral is betting is scarce, and therefore valuable, is the privacy engineering expertise to strip re-identification risk out of a dataset surgically, without destroying the statistical signal that makes it useful for AI in the first place, plus an independent risk assessment that a data buyer can’t credibly produce on its own.

How the Service Works

Integral’s Forward Deployed Privacy Services model embeds a dedicated team — statisticians, privacy engineers, software engineers, and methodologists — directly into a customer’s data pipeline, rather than delivering a one-time audit or a software tool. The work splits into two functions:

  • Entity-preserving remediation, which reduces re-identification risk while retaining the longitudinal relationships, rare cohorts, and behavioral signal that make a dataset valuable for AI applications rather than just anonymized noise.
  • Independent, continuous risk assessment, evaluated against the specific dataset, intended use case, and recipient — and re-run as the pipeline evolves, rather than treated as a static, point-in-time review.

The output is a defensibility artifact matched to whatever regulatory framework applies. In healthcare contexts, that means an Expert Determination under HIPAA §164.514(b)(1), signed by a qualified statistical expert. In other regulatory contexts, it takes the form of a signed defensibility opinion or comparable instrument.

Healthcare-Tested, Now Expanding

CEO and co-founder Shubh Sinha says the company spent four years working through this problem in healthcare — one of the most heavily regulated data environments that exists — before concluding that the real bottleneck was never data access. It was preserving the value-bearing signal in the data while managing the privacy, regulatory, and business risk that otherwise prevents its use. The company points to a pharmaceutical customer that used its service to unlock a multi-source training dataset previously considered too risky to touch, by building privacy engineering into the dataset assembly process itself rather than retrofitting controls at final review.

Integral’s methodology is grounded in peer-reviewed statistical disclosure limitation research, and the company is now extending beyond healthcare and life sciences into broader AI labs, data and annotation platforms, and enterprises looking to participate in what it’s calling the real-world data economy.

Why This Matters for the AI Data Supply Chain

As frontier labs exhaust easily-licensed public and synthetic data sources, deals for proprietary, regulated datasets are going to become a larger share of how models get trained on domain expertise — healthcare, finance, enterprise operations. That shifts the bottleneck from data availability to data defensibility: can a company prove, to a regulator or a counterparty, exactly how a dataset was cleared for use and what residual risk remains. Integral is positioning itself as infrastructure for that exact question, and the investor list — which includes LiveRamp Ventures, a firm with deep roots in data connectivity and identity resolution — suggests the privacy-layer thesis is drawing interest from data-industry incumbents as well as AI-native venture funds.